Monday, 3 August 2009

Bondronat


Biophosphonate therapy… Time for a change?

New 15 minute infusion time.

IV initiation, Oral maintenance.

Brand name: Bondronat
Generic name/category:
Ibandronic acid, Bisphosphonates
Company:
Roche
Country/Market:
UK, Europe
Indication(s)/use:
prevention and treatment of osteoporosis
Target:
Healthcare Professionals (HCP)
Tagline:
Innovative, multi-targeted bone protection
Publication:
2009

No comments:

Post a Comment